Barriers to Adoptions of IoT-Based Solutions for Disease Screening

Change of disease patterns from communicable to chronic diseases has a tremendous impact on the healthcare ecosystem. For healthcare organizations to remain viable and economically sustainable during this transition, there is a desperate need of cost-effective solutions for chronic disease management. One important strategy for this is early diagnosis and management of diseases. With rapid technological advancements, IoT-based solutions are well-positioned to be an effective tool for disease screening and health monitoring provided that they are also able to bridge non-technical barriers in technology adoption. The three primary stakeholders for screening solutions are healthcare organizations, clinical fraternity, and end-users. The primary objective of this chapter is to review likely barriers in adoptions of the IoT solutions from the perspective of these three primary stakeholders.

Download Full-text

Knowledge to action framework for home health monitoring

Healthcare Management Forum ◽

10.1177/0840470419855364 ◽

2019 ◽

Vol 32 (4) ◽

pp. 183-187

Author(s):

Christine Lee ◽

Kendall Ho

Keyword(s):

Chronic Disease ◽

Disease Management ◽

Health System ◽

Health Monitoring ◽

Chronic Disease Management ◽

Home Health ◽

Grand Challenge ◽

Science Literature ◽

Knowledge To Action ◽

Home Health Monitoring

Chronic disease management is a grand challenge, both to the patients for optimal management and to the overall health system with cost utilization. Emerging research evidence suggests that Home Health Monitoring (HHM) using home-based, remoting monitoring technologies can improve the patients’ quality of life, self-management, and achieve cost-effectiveness for the health system. How should HHM be introduced and integrated appropriately into the current healthcare delivery pathways to improve patient care and collect evidence of benefits simultaneously? The Knowledge to Action (KTA) framework is an effective approach in the implementation science literature to methodically guide the translation of evidence-based research findings into practice, putting knowledge into practical use. This article examines the use of the seven-step KTA model to address implementation facilitators and barriers of applying HHM in chronic disease management and then focus on its applicability on chronic obstructive pulmonary disease as an example.

Download Full-text

Cost effectiveness of a general practice chronic disease management plan for coronary heart disease in Australia

Australian Health Review ◽

10.1071/ah09742 ◽

2010 ◽

Vol 34 (2) ◽

pp. 162 ◽

Cited By ~ 11

Author(s):

Derek P. Chew ◽

Robert Carter ◽

Bree Rankin ◽

Andrew Boyden ◽

Helen Egan

Keyword(s):

Coronary Heart Disease ◽

General Practice ◽

Heart Disease ◽

Chronic Disease ◽

Cost Effectiveness ◽

Disease Management ◽

Financial Incentives ◽

Chronic Disease Management ◽

Cost Effective ◽

Disease Registry

Background.The cost effectiveness of a general practice-based program for managing coronary heart disease (CHD) patients in Australia remains uncertain. We have explored this through an economic model. Methods.A secondary prevention program based on initial clinical assessment and 3 monthly review, optimising of pharmacotherapies and lifestyle modification, supported by a disease registry and financial incentives for quality of care and outcomes achieved was assessed in terms of incremental cost effectiveness ratio (ICER), in Australian dollars per disability adjusted life year (DALY) prevented. Results.Based on 2006 estimates, 263 487 DALYs were attributable to CHD in Australia. The proposed program would add $115 650 000 to the annual national heath expenditure. Using an estimated 15% reduction in death and disability and a 40% estimated program uptake, the program’s ICER is $8081 per DALY prevented. With more conservative estimates of effectiveness and uptake, estimates of up to $38 316 per DALY are observed in sensitivity analysis. Conclusions.Although innovation in CHD management promises improved future patient outcomes, many therapies and strategies proven to reduce morbidity and mortality are available today. A general practice-based program for the optimal application of current therapies is likely to be cost-effective and provide substantial and sustainable benefits to the Australian community. What is known about this topic?Chronic disease management programs are known to provide gains with respect to reductions in death and disability among patients with coronary heart disease. The cost effectiveness of such programs in the Australian context is not known. What does this paper add?This paper suggests that implementing a coronary heart disease program in Australia is highly cost-effective across a broad range of assumptions of uptake and effectiveness. What are the implications for practitioners? These data provide the economic rationale for the implementation of a chronic disease management program with a disease registry and regular review in Australia.

Download Full-text